| Andrew Ostosh, | |
|
1000 Houghton Ave, Saginaw, MI 48602-5303 | |
| (989) 583-6800 | |
| Not Available |
| Full Name | Andrew Ostosh |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 1000 Houghton Ave, Saginaw, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073003208 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 430114931 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mclaren Northern Michigan | Petoskey, MI | Hospital |
| Helen Newberry Joy Hospital | Newberry, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ecs Northern Michigan Pc | 3173892627 | 20 |
| Helen Newberry Joy Hospital | 5799671285 | 30 |
News Archive
Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine.
During pregnancy, women with inflammatory arthritis usually experience disease improvement or even remission, while a disease flare regularly occurs within 3 to 4 months after delivery.
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie.
Seattle Genetics, Inc. has announced that it has initiated a phase II clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), for the retreatment of patients with Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).
› Verified 2 days ago
| Entity Name | Helen Newberry Joy Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972650935 PECOS PAC ID: 5799671285 Enrollment ID: O20040317000546 |
News Archive
Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine.
During pregnancy, women with inflammatory arthritis usually experience disease improvement or even remission, while a disease flare regularly occurs within 3 to 4 months after delivery.
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie.
Seattle Genetics, Inc. has announced that it has initiated a phase II clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), for the retreatment of patients with Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).
› Verified 2 days ago
| Entity Name | Helen Newberry Joy Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1497742050 PECOS PAC ID: 5799671285 Enrollment ID: O20100816001026 |
News Archive
Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine.
During pregnancy, women with inflammatory arthritis usually experience disease improvement or even remission, while a disease flare regularly occurs within 3 to 4 months after delivery.
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie.
Seattle Genetics, Inc. has announced that it has initiated a phase II clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), for the retreatment of patients with Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).
› Verified 2 days ago
| Entity Name | Ecs Northern Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992231377 PECOS PAC ID: 3173892627 Enrollment ID: O20170627001889 |
News Archive
Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine.
During pregnancy, women with inflammatory arthritis usually experience disease improvement or even remission, while a disease flare regularly occurs within 3 to 4 months after delivery.
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie.
Seattle Genetics, Inc. has announced that it has initiated a phase II clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), for the retreatment of patients with Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).
› Verified 2 days ago
| Entity Name | Ecs Central Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043711930 PECOS PAC ID: 9931462132 Enrollment ID: O20180423001965 |
News Archive
Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine.
During pregnancy, women with inflammatory arthritis usually experience disease improvement or even remission, while a disease flare regularly occurs within 3 to 4 months after delivery.
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie.
Seattle Genetics, Inc. has announced that it has initiated a phase II clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), for the retreatment of patients with Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).
› Verified 2 days ago
| Entity Name | Ecs Western Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992281000 PECOS PAC ID: 8628327384 Enrollment ID: O20180814003001 |
News Archive
Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine.
During pregnancy, women with inflammatory arthritis usually experience disease improvement or even remission, while a disease flare regularly occurs within 3 to 4 months after delivery.
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie.
Seattle Genetics, Inc. has announced that it has initiated a phase II clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), for the retreatment of patients with Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Ostosh, 1000 Houghton Ave, Saginaw, MI 48602-5303 Ph: () - | Andrew Ostosh, 1000 Houghton Ave, Saginaw, MI 48602-5303 Ph: (989) 583-6800 |
News Archive
Growing drug resistance, a high prevalence of S. aureus bacteria and ineffective antibiotics prescribed to one in three patients are among the challenges facing community hospitals in treating patients with serious bloodstream infections, according to researchers at Duke Medicine.
During pregnancy, women with inflammatory arthritis usually experience disease improvement or even remission, while a disease flare regularly occurs within 3 to 4 months after delivery.
Sporting events can bring a community together, such as when the Louisville Cardinals won the NCAA championship and University of Louisville campus was filled with camaraderie.
Seattle Genetics, Inc. has announced that it has initiated a phase II clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), for the retreatment of patients with Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL).
› Verified 2 days ago
Dr. Meagan Crofoot, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6800 | |
Andrew Michael Franklin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 S Washington Ave, Saginaw, MI 48601 Phone: 989-793-7220 Fax: 989-793-7482 | |
Mrs. Jayme Kern Hall, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Cooper Ave, Saginaw, MI 48602 Phone: 989-583-6521 | |
Michael Andrew Salvatore Cannova, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-746-7518 | |
Charles Hooshmand Nightingale, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 S Washington Ave, Saginaw, MI 48601 Phone: 989-907-8200 Fax: 989-907-8294 | |
Dr. Derek Schaller, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Cooper Ave, Saginaw, MI 48602 Phone: 989-583-6521 | |
Dr. Barbie Jean Fernelius, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Cooper Ave, Saginaw, MI 48602 Phone: 989-583-6521 |